Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Speaker announcement
: First Lady Jill Biden to Speak at Fierce JPM Week on January 14th
Cyclacel
Biotech
Amylyx preps for GLP-1 launch with new CCO—Chutes & Ladders
Amylyx preps for GLP-1 launch with new CCO. Andy Orth given key to the City. Antag taps Bayer vet as CEO.
Darren Incorvaia
,
Zoey Becker
Jan 10, 2025 8:30am
Investor pumps $3M into Cyclacel in return for CEO role
Jan 3, 2025 10:50am
Cash-strapped Cyclacel cuts costs while searching for salvation
Dec 6, 2024 9:11am
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Feb 2, 2024 9:30am
Cyclacel passes phase 3 leukemia drug rights back to Daiichi
Nov 10, 2022 10:05am
Phase 1 data backs Cyclacel’s plans for CDK2/9 inhibitor
Apr 16, 2018 9:38am